The Pharmaceutical Journal
Vol 270 No 7235 p177
8 February 2003

This article
Reprint
Photocopy

News summary

Related websites
Committee on Safety of Medicines recommendation (more)

Vigilance required with methotrexate labels, says CSM

Pharmacists have been advised by the Department of Health to be vigilant in ensuring that dispensing labels for oral methotrexate products accurately reflect the intended dosage. Following a number of medication errors, the Committee on Safety of Medicines has recommended a change to the labelling of oral methotrexate products to include the statement: "Check dose and frequency — methotrexate is usually given once a week." Revised packaging will be available shortly.